Ortin Global Ltd Quarterly Results
Q1 FY12-13 Results Summary
Revenue
The revenue stands at ₹15.93 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.42 per cent from ₹19.77 crore. This corresponds to a year-on-year *(YoY) decline of 19.42 per cent.
Operating Profit
Operating Profit stands at ₹2.08 crore, reflecting a quarter-on-quarter *(QoQ) increase of 308.00 per cent from ₹-1.00 crore. This corresponds to a year-on-year *(YoY) growth of 308.00 per cent.
PBDT
PBDT stands at ₹0.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 155.31 per cent from ₹-1.79 crore. This corresponds to a year-on-year *(YoY) growth of 155.31 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 130.28 per cent from ₹-2.18 crore. This corresponds to a year-on-year *(YoY) growth of 130.28 per cent.
Net Profit
Net Profit stands at ₹0.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 122.92 per cent from ₹-1.92 crore. This represents a 122.92 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Ortin Global Ltd Earnings
- YOY
- QOQ
Ortin Global Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ortin Global Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Ortin Global Ltd Financial Reports
Ortin Global Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ortin Global | -2.68% | 3.10% | 3.31% | 8.37% | -2.74% | 18.63% |
| Norris Medicines | -2.51% | 3.58% | -3.05% | 22.31% | 18.66% | -7.83% |
| Desh Rakshak | 0.00% | 4.47% | -13.23% | -1.61% | -4.78% | -67.44% |
| Dipna Pharmachem | 12.94% | 15.20% | 6.67% | -22.27% | -53.66% | -71.31% |
| Unjha Formul. | 2.04% | 1.47% | 2.11% | 37.75% | 17.79% | 11.63% |
| Kobo Biotech | -5.00% | -18.31% | -46.73% | 90.00% | 77.51% | 116.46% |
| Beryl Drugs | 1.77% | -4.65% | 8.15% | 14.18% | 4.32% | 10.92% |
Company Info
Company Information
Managing Director : S Murali Krishna Murthy
Non Executive Director : Pramod Dnyandeo Wag He
Independent Director : Mounika Pammi
Whole-time Director : Prashant Prakash Sawant
Whole-time Director : Prakruti Prakash Sawant
Chairman & Independent Directo : Sarang Balbhimrao Patodekar
Independent Director : Ajay Vishwakarma
Company Sec. & Compli. Officer : Madhu Solanki